insights_auto
Why is DHR up 3.22%?
Dive Deeperchevron_right
DHR:BMV
Danaher Corp
MX$4,010.00
arrow_upward
+3.22%(+125.00) 1D
Oct 9, 2:00:00 PM GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DHR...
Open
MX$4,011.00
High
MX$4,011.00
Low
MX$4,010.00
Mkt. cap
154.52B
Avg. vol.
34.00
Volume
202.00
52-wk high
MX$4,273.97
52-wk low
MX$2,795.00
Shares outstanding
700.90M
No. of employees
59K
Open
MX$4,011.00
High
MX$4,011.00
Low
MX$4,010.00
Mkt. cap
154.52B
Avg. vol.
34.00
Volume
202.00
52-wk high
MX$4,273.97
52-wk low
MX$2,795.00
Shares outstanding
700.90M
No. of employees
59K
News stories
From web sources and news partners
AD HOC NEWS
·
10 hours ago
Danaher plans AI lab as Danaher stock costs EUR 196.50
AD HOC NEWS
·
21 hours ago
Danaher stock at USD 219.87 on October 9, 2026
AD HOC NEWS
·
1 day ago
Barclays raises target for Danaher stock to USD 255.00
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp